Jazz Pharmaceuticals Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc.
SHPGShire PLC Sponsored ADR
PRGOPerrigo Co. Plc
MNKMallinckrodt Plc
SAGESAGE Therapeutics, Inc.
JAZZJazz Pharmaceuticals Plc
PTLAPortola Pharmaceuticals, Inc.
UTHRUnited Therapeutics Corporation
GWPHGW Pharmaceuticals PLC Sponsored ADR
MDCOMedicines Company
ENDPEndo International Plc
ICPTIntercept Pharmaceuticals, Inc.
SUPNSupernus Pharmaceuticals, Inc.
PCRXPacira Pharmaceuticals, Inc.

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd on January 18, 2012 and is headquartered in Dublin, Ireland.